Taylor Sandison - 30 Sep 2021 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
Chief Medical Officer
Signature
/s/ Taylor Sandison
Issuer symbol
CDTX
Transactions as of
30 Sep 2021
Net transactions value
$0
Form type
4
Filing time
04 Oct 2021, 21:31:08 UTC
Next filing
07 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDTX Common Stock Award $0 +150,600 +175% $0.000000 236,631 30 Sep 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All RSUs vest in three equal annual installments, with 1/3 vesting on each of September 10, 2022, 2023, and 2024, subject to continuous service through each such vesting date.
F2 Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 20, 2021.